Literature DB >> 16581652

Immunohistological localisation of human FAT1 (hFAT) protein in 326 breast cancers. Does this adhesion molecule have a role in pathogenesis?

Nantana Kwaepila1, Gordon Burns, Anthony S-Y Leong.   

Abstract

AIMS: To examine the immunohistological expression in human breast cancers of human FAT1 (hFAT) protein, a recently described member of the cadherin superfamily, and its correlation with histological type and grade.
METHODS: A total of 326 cases of invasive and in situ breast cancer representing a broad spectrum of histological subtypes were immunostained with affinity-purified rabbit antibodies produced to the cytoplasmic region of hFAT using a standard avidin-biotin system. Staining intensity was arbitrarily graded on a scale of 0 to 3.
RESULTS: All tumours showed diffuse staining for hFAT. Immunoexpression of the protein was generally strong in both lobular (LCIS, n = 2) and ductal in situ carcinoma (DCIS, n = 55). hFAT was also strongly immunoexpressed in all types of invasive carcinoma. Grade 3 DCIS displayed the highest hFAT intensity compared with lower grade tumours, with significant differences between grade 1 and 3 (p = 0.015) and grade 2 and 3 (p = 0.047). With invasive ductal carcinomas (n = 128) the difference was not as clear-cut, as most tumours showed moderate (n = 63) or strong staining (n = 49), although grade 3 IDC revealed significantly decreased immunoexpression compared with grade 1 IDC (p = 0.03).
CONCLUSIONS: The results illustrate that hFAT1 does not display the pattern of expression seen with the E-cadherin-ss-catenin adhesion complex; however, its over-expression and diffuse expression in both in situ and invasive carcinoma strongly suggests a role in carcinogenesis. From the known functions of FAT1 it is suggested that the concurrent loss of classical cadherins from cell-cell junctions accompanied by increased FAT1 expression contributes to loss of duct formation, and increased cell migration and invasion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16581652     DOI: 10.1080/00313020600559975

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  15 in total

1.  T-cell acute lymphoblastic leukemias express a unique truncated FAT1 isoform that cooperates with NOTCH1 in leukemia development.

Authors:  Charles E de Bock; Michelle Down; Kinsha Baidya; Bram Sweron; Andrew W Boyd; Mark Fiers; Gordon F Burns; Timothy J Molloy; Richard B Lock; Jean Soulier; Tom Taghon; Pieter Van Vlierberghe; Jan Cools; Jeff Holst; Rick F Thorne
Journal:  Haematologica       Date:  2018-12-04       Impact factor: 9.941

2.  Vaccination With a FAT1-Derived B Cell Epitope Combined With Tumor-Specific B and T Cell Epitopes Elicits Additive Protection in Cancer Mouse Models.

Authors:  Alberto Grandi; Laura Fantappiè; Carmela Irene; Silvia Valensin; Michele Tomasi; Simone Stupia; Riccardo Corbellari; Elena Caproni; Ilaria Zanella; Samine J Isaac; Luisa Ganfini; Luca Frattini; Enrico König; Assunta Gagliardi; Simona Tavarini; Chiara Sammicheli; Matteo Parri; Guido Grandi
Journal:  Front Oncol       Date:  2018-10-26       Impact factor: 6.244

3.  Biologic characteristics of premalignant breast disease.

Authors:  Kimberly Cole; Maria Tabernero; Karen S Anderson
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

4.  Dual processing of FAT1 cadherin protein by human melanoma cells generates distinct protein products.

Authors:  Elham Sadeqzadeh; Charles E de Bock; Xu Dong Zhang; Kristy L Shipman; Naomi M Scott; Chaojun Song; Trina Yeadon; Camila S Oliveira; Boquan Jin; Peter Hersey; Andrew W Boyd; Gordon F Burns; Rick F Thorne
Journal:  J Biol Chem       Date:  2011-06-16       Impact factor: 5.157

Review 5.  The Atypical Cadherin FAT1 Limits Mitochondrial Respiration and Proliferation of Vascular Smooth Muscle Cells.

Authors:  Dario F Riascos-Bernal; Alishba Maira; Nicholas E S Sibinga
Journal:  Front Cardiovasc Med       Date:  2022-05-11

6.  Expression and associated epigenetic mechanisms of the Ca2+-signaling genes in breast cancer subtypes and epithelial-to-mesenchymal transition.

Authors:  Andrés Hernández-Oliveras; Ángel Zarain-Herzberg
Journal:  J Cell Commun Signal       Date:  2021-11-11       Impact factor: 5.908

Review 7.  Cell polarity as a regulator of cancer cell behavior plasticity.

Authors:  Senthil K Muthuswamy; Bin Xue
Journal:  Annu Rev Cell Dev Biol       Date:  2012-08-06       Impact factor: 13.827

8.  A synthetic lethal screen identifies FAT1 as an antagonist of caspase-8 in extrinsic apoptosis.

Authors:  Dominique Kranz; Michael Boutros
Journal:  EMBO J       Date:  2014-01-17       Impact factor: 11.598

9.  FAT1: a potential target for monoclonal antibody therapy in colon cancer.

Authors:  Piero Pileri; Susanna Campagnoli; Alberto Grandi; Matteo Parri; Elisa De Camilli; Chaojun Song; Luisa Ganfini; Aurelien Lacombe; Ilaria Naldi; Paolo Sarmientos; Caterina Cinti; Boquan Jin; Guido Grandi; Giuseppe Viale; Luigi Terracciano; Renata Grifantini
Journal:  Br J Cancer       Date:  2016-06-21       Impact factor: 7.640

10.  A soluble form of the giant cadherin Fat1 is released from pancreatic cancer cells by ADAM10 mediated ectodomain shedding.

Authors:  Nathalie Wojtalewicz; Elham Sadeqzadeh; Jakob V Weiß; Mahnaz Moradian Tehrani; Susanne Klein-Scory; Stephan Hahn; Wolff Schmiegel; Uwe Warnken; Martina Schnölzer; Charles E de Bock; Rick F Thorne; Irmgard Schwarte-Waldhoff
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.